Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online May 7, 2007
Diabetes Care 30:2057-2063, 2007
DOI: 10.2337/dc07-0063
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-0063v1
30/8/2057    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giunti, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giunti, S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Article

Incidence and Risk Factors of Prolonged QTc Interval in Type 1 Diabetes

The EURODIAB Prospective Complications Study

Sara Giunti, MD1, Graziella Bruno, MD1, Emma Lillaz, MD1, Gabriella Gruden, MD1, Valentina Lolli, MD1, Nish Chaturvedi, MD2, John H. Fuller, MD3, Massimo Veglio, MD4, Paolo Cavallo-Perin, MD1 The EURODIAB IDDM Complications Study Group*

1 Department of Internal Medicine, University of Torino, Torino, Italy
2 International Centre for Circulatory Health and National Heart and Lung Institute, Imperial College, London, U.K.
3 Department of Epidemiology and Public Health, University College London, London, U.K.
4 Ospedale Evangelico Valdese, Torino, Italy

Address correspondence and reprint requests to Prof. Graziella Bruno, Department of Internal Medicine, University of Torino, 14, C.so A.M. Dogliotti, I-10126 Torino, Italy. E-mail: graziella.bruno{at}unito.it

OBJECTIVE—Corrected QT (QTc) prolongation is predictive of cardiovascular mortality in both the general and diabetic populations. As part of the EURODIAB Prospective Complication Study, we have assessed the 7-year incidence and risk factors of prolonged QTc in people with type 1 diabetes.

RESEARCH DESIGN AND METHODS—A total of 1,415 type 1 diabetic subjects, who had normal QTc at baseline, were reanalyzed after the 7-year follow-up period. QTc >0.44 s was considered abnormally prolonged.

RESULTS—Cumulative incidence of prolonged QTc was 18.7%, which is twofold higher in women than in men (24.5 vs. 13.9%, P < 0.0001). At the baseline examination, incident cases were older and less physically active than nonincident cases, had higher mean values of systolic blood pressure and HDL cholesterol, and had higher frequencies of hypertension, coronary heart disease, and distal symmetrical polyneuropathy. In multivariate logistic regression analyses, female sex and higher values of A1C and systolic blood pressure were associated with the risk of prolonged QTc, whereas physical activity and BMI within the range of 21.5–23.2 kg/m2 were protective factors. In women, association with modifiable factors, particularly BMI, was stronger than in men.

CONCLUSIONS—In type 1 diabetic subjects from the EURODIAB cohort, female sex, A1C, and systolic blood pressure are predictive of prolonged QTc, whereas physical activity and BMI within the range of 21.5–23.2 kg/m2 play a protective role. These findings are clinically relevant, as they may help to identify subjects at higher risk for prolonged QTc, as well as provide potential targets for risk-lowering strategies.

Abbreviations: AER, albumin excretion rate • CHD, coronary heart disease • ECG, electrocardiogram


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
G. Gruden, G. Bruno, N. Chaturvedi, D. Burt, C. Schalkwijk, S. Pinach, C. D. Stehouwer, D. R. Witte, J. H. Fuller, P. C. Perin, et al.
Serum Heat Shock Protein 27 and Diabetes Complications in the EURODIAB Prospective Complications Study: A Novel Circulating Marker for Diabetic Neuropathy
Diabetes, July 1, 2008; 57(7): 1966 - 1970.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.